3Labeit S, mid Kolmerer B. Titins: giant proteins in charge of muscle ultrastructureand dasticity [J]. Sdence, 1995, 270 (5234): 293 - 296.
4Aarli JA, Stefansson K, Marton LS, et al. Patients, vith myasthenia gravis and thymoma have in their sera IgG autoantibodies against titinp [J]. Clin Exp Immunol. 1990, 82 (2): 284-288.
5Gautel M, Lakey A, Barlow DP, et al. Titin antibodies in myasthenia gravis: identification of a major immunogenic region of titin [J]. Neurology, 1993. 43 (8): 1581-1585.
6Romi E Skeie GO, Aarli JA, et al. The severity ofmyasthenia graviscorrelates with the serilln concentration of fitin and ryanodine receptor antibodies [J]. Arch Neurol, 2000, 57 (11): 1596- 1600.
2Romi F, Skeie GO, Aarli JA, et al. Muscle autoantibodies in subgroups of myasthenia gravis patients. J Neurol, 2000, 247:369.
3Gautel M, Lakey A, Barlo DP, et al. Titin antibodies in myasthenia gravis: identification of a major immunogenic region of titin. J Neurol, 1993, 43: 1581.
4Yamamoto AM, Gajdos P, Eymard B, et al. Anti-titin antibodies in myasthenia gravis: tight association with thymoma and heterogeneity of nonthymoma patients. Arch Neurol, 2001, 58:885.
5Romi F, Skeie GO, Aarli JA, et al. The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies. Arch Neurol, 2000, 57: 1596.
6Skeie GO, Freiburg A, Kolmerer B, et al. Titin transcripts in thymomas. Ann N Y Acad Sci, 1998, 841: 422.
